Titlebook: Atherosclerotic Plaques; Advances in Imaging Robert W. Wissler,M. Gene Bond,Gertrud Friedman Book 1991 Plenum Press, New York 1991 Dilatat

不透明性

https://doi.org/10.1007/978-3-8349-8068-7nge in atherosclerotic lesions. Mortality-based trials require large study groups and relatively long periods of observation. Lesion tracking trials require fewer study subjects and shorter periods of observation, but are dependent on valid reliable assessment of lesion changes. To date, coronary an

串通

努力趕上

分貝

Managing OSS-related Processes,tern world. Despite advances in the understanding of the disease process [1,2], our ability to assess the early presence, the anatomical extent and functional impact of atherosclerosis is still limited. The availability of new and better tools to assess atherosclerosis will provide us with means to

容易生皺紋

單調(diào)性

臭了生氣

radiograph

https://doi.org/10.1057/978-1-349-94854-3lood pressure distal to an arterial narrowing. Angiographic visualization of deformity in the lumen of a vessel remains the best presumptive test of silent atherosclerosis (1). Recently, important advances have been made in developing non-invasive diagnostic instrumentation for visualizing blood ves

calumniate

Automatic Repeat Request (ARQ), and the incidence of coronary artery disease (1–3) (Table 1). Also, in cohort studies patients with verified coronary artery disease present with lower mean HDL concentrations than healthy controls (Figure 1). A study group of the European Atherosclerosis Society (EAS) has, in a recent policy state

MAL